首页> 美国卫生研究院文献>Cancers >Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging
【2h】

Living Donor Liver Re-Transplantation for Recurrent Hepatoblastoma in the Liver Graft following Complete Eradication of Peritoneal Metastases under Indocyanine Green Fluorescence Imaging

机译:在吲哚菁绿色荧光成像下彻底清除腹膜转移后肝移植物中复发性肝母细胞瘤的活体供体肝再移植

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The curability of chemotherapy-resistant hepatoblastoma (HB) largely depends on the achievement of radical surgical resection. Navigation techniques utilizing indocyanine green (ICG) are a powerful tool for detecting small metastatic lesions. We herein report a patient who underwent a second living donor liver transplantation (LDLTx) for multiple recurrent HBs in the liver graft following metastasectomy for peritoneal dissemination with ICG navigation. The patient initially presented with ruptured HB at 6 years of age and underwent 3 liver resections followed by the first LDLTx with multiple sessions of chemotherapy at 11 years of age. His alpha-fetoprotein (AFP) level increased above the normal limit, and metastases were noted in the transplanted liver and peritoneum four years after the first LDLTx. The patient underwent metastasectomy of the peritoneally disseminated HBs with ICG navigation followed by the second LDLTx for multiple metastases in the transplanted liver. The patient has been recurrence-free with a normal AFP for 30 months since the second LDLTx. To our knowledge, this report is the first successful case of re-LDLTx for recurrent HBs. Re-LDLTx for recurrent HB can be performed in highly select patients, and ICG navigation is a powerful surgical tool for achieving tumor clearance.
机译:化疗耐药性肝母细胞瘤(HB)的可治愈性在很大程度上取决于根治性手术切除的实现。利用吲哚菁绿(ICG)的导航技术是检测微小转移灶的有力工具。我们在此报告了一名患者,该患者接受了第二次活体供体肝移植(LDLTx),并在接受了ICG导航的腹膜切除术后肝移植物中发生了多个复发性HBs。该患者最初在6岁时出现HB破裂,并进行了3次肝切除术,随后进行了首次LDLTx,并在11岁时进行了多次化疗。他的甲胎蛋白(AFP)水平升高至正常水平以上,并且在首次LDLTx四年后在移植的肝和腹膜中发现转移。该患者接受了ICG导航,进行了腹膜弥漫性HBs的转移瘤切除术,随后进行了第二次LDLTx移植肝的多处转移。自第二次LDLTx以来,患者的AFP正常无复发30个月。据我们所知,该报告是复发性HBs的首例成功的LDLTx成功案例。 Re-LDLTx用于复发性HB可以在高度选择的患者中进行,并且ICG导航是实现肿瘤清除的强大手术工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号